CNS Pharmaceuticals Announces 1-For-30 Reverse Stock Split Effective At 4:01 p.m. EST Nov. 28, 2022
CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain